ITC can provide an estimate of the relative treatment effect of two products that have not been comp...
Read moreWe’ve prepared a summary of our key market access blogs and news articles from the second quarter ...
Read moreRemap Consulting has significant expertise in guiding companies through both EUnetHTA / EMA Parallel...
Read moreTo tackle antibiotic resistance, novel antibiotics are being reserved as later-line therapy for more...
Read morePayers are responsible for making choices on which products or services to fund from limited healthc...
Read more"Payer" generally refers to people or bodies other than the patient that finance or refund the cost ...
Read moreWhat is the future of precision medicine in the EU? The field of precision medicine is a complex are...
Read moreUnderstanding payer value and evidence requirements to secure pricing and reimbursement for an oncol...
Read moreSupporting in identifying and obtaining payer scientific advice to inform a Phase III trial design.
Read moreThe objective of this research was to understand the processes and outputs from different European p...
Read more